Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases.

[1]  G. Janossy,et al.  Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21). , 1996, Blood.

[2]  B. Drénou,et al.  P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML). , 1994, Leukemia.

[3]  T. Holyoake,et al.  CD34+ positive haemopoietic cells: biology and clinical applications. , 1994, Blood reviews.

[4]  S. Tura,et al.  Alpha-methyldopa-type autoimmune hemolytic anemia caused by lobenzarit disodium of a mefenamic acid derivative and immunomodulator. , 1994 .

[5]  P. Sonneveld,et al.  Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. , 1993, Blood.

[6]  J. Magaud,et al.  High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. , 1993, Blood.

[7]  A. Pascarella,et al.  CD34 expression fails to predict the outcome in adult acute myeloid leukemia. , 1993, Haematologica.

[8]  E. Thiel,et al.  Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. , 1993, Leukemia.

[9]  N. Lucie,et al.  The prognostic significance of the CD34 antigen in acute myeloid leukaemia. , 1992, Leukemia & lymphoma.

[10]  J. Griffin,et al.  Prognostic value of lymphocyte surface markers in acute myeloid leukemia. , 1991, Blood.

[11]  S. Piantadosi,et al.  Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10) , 1990, British journal of haematology.

[12]  M. Greaves,et al.  The hemopoietic stem cell antigen, CD34, is encoded by a gene located on chromosome 1. , 1989, Leukemia.

[13]  D. Treille,et al.  Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy , 1989, British journal of haematology.

[14]  S. Bigner,et al.  Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. , 1989, American journal of clinical pathology.

[15]  D. Weisenburger,et al.  Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). , 1988, Leukemia.

[16]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[17]  M. Fackler,et al.  Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. , 1984, Journal of immunology.

[18]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[19]  S. Tura,et al.  The presence of lymphoid‐associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance , 1995, Stem cells.

[20]  F. Lanza,et al.  Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia. , 1994, Leukemia & lymphoma.

[21]  C. Civin,et al.  Antigenic analysis of hematopoiesis: a review. , 1993, Journal of hematotherapy.